News for BioLargo, Inc. (BLGO)

Release Date: May 15, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BioLargo Inc (BLG

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NBLGO.PK - BioLargo IncQ1 2025 BioLargo Inc Earnings CallMay 15, 2025 / 08:30PM GMT ===========

BioLargo (OTCQX:BLGO) to host Q1 2025 earnings webcast and conference call on May 15, 2025, at 4:30 PM Eastern Time. The event will discuss financial re

WESTMINSTER, CA / ACCESS Newswire / May 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve toug

BioLargo (BLGO) has unveiled case study results that demonstrate its AEC PFAS solution can achieve over 80% savings in lifecycle costs while effectively capturi

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced ...

Operator: Good day, everyone, and welcome to the BioLargo Annual 2024 Earnings Results. At this time, all participants have been placed on a listen-only mode.

**media[582784]**

BioLargo, Inc. (OTCQX:BLGO) Q4 2024 Earnings Conference Call March 31, 2025 4:00 PM ETCompany ParticipantsBrian Loper - Investor RelationsDennis Calvert -...

WESTMINSTER, CALIFORNIA / ACCESS Newswire / March 28, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental

**media[575014]**

Company will report on successful removal and destruction of PFAS from landfill leachate at the Air & Waste Management Association's - The Science of PFAS Confe

Continued Strong Revenue Growth; Zero Share Dilution in 2nd Half of 2024 WESTMINSTER, CA / ACCESSWIRE / January 15, 2025 / BioLargo, Inc. (OTCQX:BLGO), a compan

WESTMINSTER, CA / ACCESSWIRE / December 12, 2024 / BioLargo, Inc. (OTCQX:BLGO), a company that creates and commercializes sustainable technologies to solve toug

Dennis Calvert, President & CEO of BioLargo Inc. BLGO, was recently a guest on Benzinga's All-Access. BioLargo is a cleantech and life sciences innovator and e...

**media[440662]**

Revenue: $5 million for the three months ended June 30, 2024, and $9.8 million for the six months.Gross Profit: Over $2 million for the three months and $4.4 m

Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY

Operator: Greetings. Welcome to the BioLargo Second Quarter 2024 Earnings Results Conference Call. At this time, all participants are in a listen-only mode.